心脏CT晚期碘强化用于心肌组织特征描述的诊断准确性:系统评价与Meta分析
该系统评价与Meta分析纳入14项研究、526例患者和5758个心肌节段,以心脏磁共振晚期钆强化为参考标准,评估心脏CT晚期碘强化的诊断准确性。患者水平汇总敏感度0.96、特异度0.95、HSROC AUC 0.98;节段水平敏感度0.86、特异度0.98、AUC 0.97;双能CT将节段水平敏感度提高至0.93。结论认为晚期碘强化诊断准确性优秀,可能成为心脏磁共振的有前景替代方法。
要点
- 患者水平:晚期碘强化诊断心肌组织异常的汇总敏感度0.96、特异度0.95,HSROC AUC 0.98。
- 节段水平:汇总敏感度0.86、特异度0.98,HSROC AUC 0.97,特异度高于敏感度。
- 双能CT将节段水平敏感度提高至0.93(95%CI 0.88-0.96),优于整体节段水平0.86。
核心结论
- 心脏CT晚期碘强化与心脏磁共振晚期钆强化相比,用于心肌组织特征描述显示出优秀的诊断准确性,提示其可能成为心脏磁共振的有前景替代方法。
研究设计与样本
- 系统评价与Meta分析,检索EMBASE、PubMed/MEDLINE和CENTRAL,纳入14项以心脏磁共振晚期钆强化为参考标准评估心脏CT晚期碘强化准确性的研究,共526例患者和5758个心肌节段,采用QUADAS-2评估偏倚风险,双变量随机效应模型汇总诊断性能指标,Prospero注册号CRD42023484045。
诊断标准与关键数值
- 患者水平:汇总敏感度0.96(95%CI 0.88-0.99)、特异度0.95(95%CI 0.88-0.98)、HSROC AUC 0.98(95%CI 0.97-0.99)、+LR 20.97(95%CI 7.54-58.38)、-LR 0.04(95%CI 0.01-0.13)、DOR 535(95%CI 94-3024);节段水平:敏感度0.86(95%CI 0.79-0.91)、特异度0.98(95%CI 0.96-0.99)、HSROC AUC 0.97(95%CI 0.95-0.98)、+LR 55.08(95%CI 19.94-152.16)、-LR 0.14(95%CI 0.09-0.22)、DOR 388(95%CI 113-1333);双能CT节段水平敏感度0.93(95%CI 0.88-0.96)。
临床应用与阅片要点
- 作者认为心脏CT晚期碘强化提供了心脏磁共振晚期钆强化的可靠替代方法,尤其适用于心脏磁共振不可用、不可行或存在禁忌证的患者,从而改善心肌组织特征描述的可及性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: to evaluate the diagnostic accuracy of late iodine enhancement (LIE) in cardiac computed tomography (CCT) compared to late gadolinium enhancement (LGE) in cardiac magnetic resonance (CMR) for myocardial tissue characterization.
MATERIALS AND METHODS: EMBASE, PubMed/MEDLINE, and CENTRAL were searched for studies reporting the accuracy of LIE with LGE as the gold standard of reference. QUADAS-2 tool was used to assess the risk of bias. A bivariate random-effects model was used to analyze, pool, and plot the diagnostic performance measurements across studies. Pooled sensitivity, specificity, positive (+LR) and negative (-LR) likelihood ratio, diagnostic odds ratio (DOR), and hierarchical summary ROC curve (HSROC) were computed. Prospero registration number: CRD42023484045.
RESULTS: Fourteen studies involving 526 patients and 5758 myocardial segments were included. At the patient level, LIE in CCT showed a pooled sensitivity of 0.96 (95% CI: 0.88-0.99), specificity of 0.95 (95% CI: 0.88-0.98) and the HSROC AUC of 0.98 (95% CI: 0.97-0.99). The +LR was 20.97 (95% CI: 7.54-58.38) and the -LR was 0.04 (95% CI: 0.01-0.13), resulting in a DOR of 535 (95% CI: 94-3024). At the segment level, sensitivity was 0.86 (95% CI: 0.79-0.91), specificity was 0.98 (95% CI: 0.96-0.99), and the HSROC AUC was 0.97 (95% CI:0.95-0.98). The +LR was 55.08 (95% CI: 19.94-152.16) and the -LR was 0.14 (95% CI: 0.09-0.22) with a DOR of 388 (95% CI: 113-1333). Dual-energy CCT improved segment-level sensitivity to 0.93 (95% CI: 0.88-0.96).
CONCLUSION: LIE in CCT shows excellent diagnostic accuracy when compared to LGE in CMR for myocardial tissue characterization, suggesting its potential as a promising alternative to CMR.
KEY POINTS: Question How does myocardial tissue characterization by late iodine enhancement (LIE) on cardiac CT (CCT) compare to late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR)? Findings LIE in CCT demonstrates excellent diagnostic accuracy, with high sensitivity and specificity at both patient and segment levels, using LGE in CMR as the reference. Clinical relevance LIE in CCT provides a reliable alternative to LGE in CMR, especially for patients for whom CMR is not available or feasible or is contraindicated, thus improving access to myocardial tissue characterization.
引用
- Gatti M, De Filippo O, Cura Curà G, et al. Diagnostic accuracy of late iodine enhancement on cardiac CT for myocardial tissue characterization: a systematic review and meta-analysis. Eur Radiol. 2024. PMID: 39702631. doi:10.1007/s00330-024-11283-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。